The S&P 500 has continued to climb in 2026, but the rally has not helped every company in the index. While major benchmarks are pushing toward new highs, several well-known stocks remain stuck near deeply depressed levels.
This split has created an unusual market setup. On one side, investor confidence has improved, earnings expectations have strengthened, and Wall Street strategists have raised year-end targets. Conversely, a group of S&P 500 companies has fallen sharply from recent highs due to customer losses, product issues, slowing growth, analyst downgrades, and shifts in competitive conditions.
On May 29, the S&P 500 closed at 7,580.06 after gaining 0.22% for the session. The index rose 1.49% for the week and ended the month up more than 5%. Technology stocks helped lead the move, while improving geopolitical sentiment also supported risk appetite.
Goldman Sachs Research added to the bullish mood by lifting its year-end S&P 500 target to 8,000 from 7,600. The firm said earnings growth has been the main driver of the market’s strength, rather than a major expansion in valuations. Goldman Sachs expects S&P 500 earnings per share to reach $340 in 2026 and $385 in 2027.
However, not every stock is participating in the rally. The following 10 S&P 500 names stood out on a May 29 screen for their large declines from 52-week highs, weak Relative Strength Index readings, hedge fund ownership trends, and recent company developments.
1. CoStar Group
CoStar Group (NASDAQ: CSGP) was one of the weakest S&P 500 performers in the May 29 screen. The stock had fallen 66.85% from its 52-week high and carried a Relative Strength Index of 34.08.
Even after that sharp decline, analyst sentiment remained positive. Wall Street still showed a Strong Buy consensus based on 14 analyst recommendations, with an average upside potential of about 57% at the time of the screen.
The company also announced a major acquisition that could influence its long-term growth path. On May 29, CoStar said it had agreed to buy Zonda, a housing market data provider, for $800 million in cash.
The purchase would deepen CoStar’s reach in home construction data and expand its real estate marketplace portfolio through NewHomeSource.com. The deal is expected to close in the second half of 2026, subject to customary closing conditions and regulatory approvals.
CoStar expects the transaction to add to adjusted earnings per share in the first full year after ownership. Hedge fund interest also remained meaningful, with 62 funds holding positions in the company as of the first quarter.
2. Charter Communications
Charter Communications (NASDAQ: CHTR) ranked second after falling 65.13% from its 52-week high. The company has been under pressure due to broadband subscriber losses and increasing competition from telecom companies.
In the first quarter of 2026, Charter lost 120,000 internet customers. That figure was worse than analysts had expected, raising further concerns about the company’s Spectrum broadband business.
The video business also continued to shrink, although the pace of losses improved from the prior year. Charter lost 60,000 video customers in the quarter, compared with a decline of 181,000 customers in the first quarter of 2025.
Revenue fell 1% year over year to $13.6 billion. Net income attributable to Charter shareholders declined to $1.16 billion.
As of the screen, Charter’s Relative Strength Index stood at 36.16. Hedge fund ownership also declined, dropping from 62 funds in the fourth quarter of 2025 to 48 funds in the first quarter of 2026.
The company remains one of the largest broadband and cable providers in the United States. Investors are now watching whether Charter can slow internet customer losses, defend pricing, and protect profitability in a tougher competitive environment.
3. Intuit
Intuit (NASDAQ: INTU) has become one of the most notable technology selloffs of the year. At the time of the May 29 screen, the stock was down 61.53% from its 52-week high and had lost more than half its value over the previous 12 months.
The decline reflects growing investor concern that artificial intelligence could disrupt parts of Intuit’s tax, accounting, and small business software ecosystem.
Sentiment weakened further after Intuit announced plans to cut 17% of its full-time workforce. The company said the move was part of a broader effort to simplify operations, reduce management layers, remove overlap, and focus more heavily on strategic priorities such as AI.
Quarterly revenue growth also came in below analyst expectations, adding to pressure on the stock.
Even after the steep sell-off, analysts remained broadly optimistic. Intuit still carried a Strong Buy consensus and showed average upside potential of about 51% as of the screen.
J.P. Morgan reaffirmed a Buy rating with a $605 price target, while BofA began coverage with a Buy rating and a $400 target. As of the first quarter, 92 hedge funds held positions in Intuit.
4. Insulet
Insulet (NASDAQ: PODD) has faced a difficult period as product concerns and legal developments have weighed on investor confidence. The stock was down 59.84% from its 52-week high and had a Relative Strength Index of 29.26 in the May 29 screen.
The company came under pressure after announcing a voluntary correction for specific production lots of its Omnipod insulin delivery products. The affected products included certain Omnipod 5, Omnipod DASH, and Omnipod Insulin Management System pods.
Insulet said the issue involved a manufacturing defect that could cause insulin to be delivered at a lower level than intended. In some affected pods, insulin may escape outside the intended delivery path rather than being properly administered.
That type of malfunction can raise blood glucose levels and may create serious health risks for users, including diabetic ketoacidosis. The action was separate from another Omnipod 5 correction announced earlier in March.
The company also faced a legal setback in a trade secrets case involving EOFlow. A Washington appeals court overturned a $59 million verdict that had previously gone in Insulet’s favor, ruling that the company waited too long to bring the claim.
The stock remains under pressure as investors assess product reliability, legal risk, and the company’s long-term position in the diabetes care market.
5. Boston Scientific
Boston Scientific (NYSE: BSX) was also among the major healthcare names trading far below its recent high. The stock had declined 55.15% from its 52-week high at the time of the May 29 screen.
Hedge funds still showed significant interest in the company. A total of 106 hedge funds reported positions in Boston Scientific, the highest count among the stocks on this list.
The recent pressure has been tied partly to questions about growth in the Watchman implant business. The device is used to reduce stroke risk in certain patients, and investors had previously assigned high expectations to that product line.
Those concerns led Wolfe Research to downgrade the stock from Outperform to Peer Perform. TD Cowen also reduced its price target to $61 from $80, while maintaining a Buy rating.
Despite the weaker sentiment, Boston Scientific still carried a Strong Buy consensus from Wall Street. Analysts saw an average upside potential of about 70% as of the screen.
The company remains a major medical device player, but investors now want stronger evidence that growth across key product categories can meet long-term expectations.
6. Zoetis
Zoetis (NYSE: ZTS) had one of the weakest technical readings in the group. The stock had dropped sharply from its 52-week high and carried a Relative Strength Index of 26.21.
The animal health company has been dealing with softer demand in parts of its business, especially in companion animal care.
Argus Research downgraded the stock from Buy to Hold in late May. The firm cited increased competition, changing demand patterns, and the possibility that newer products could reduce sales from parts of Zoetis’ existing portfolio.
The downgrade followed a weaker first quarter. Zoetis reported revenue of $2.3 billion, up 3% from the prior year, but organic operational growth was flat. The company also reduced its full-year outlook after demand softened.
Management pointed to a more cautious pet owner environment, with some consumers cutting back on veterinary visits and higher-end pet healthcare treatments.
Still, analysts projected an average upside potential of about 53% as of the screen. That suggests some on Wall Street believe the market may be pricing in too much bad news.
7. Tractor Supply Company
Tractor Supply (NASDAQ: TSCO) has also suffered a sharp pullback, with shares down 50.98% from their 52-week high on May 29. However, the company continues to invest in areas that could support future growth.
On May 28, Tractor Supply announced the acquisition of VIP Petcare from PetIQ. VIP Petcare operates mobile veterinary clinics and serves more than 1 million pets each year through nearly 2,700 retail locations across 39 states.
The transaction expands Tractor Supply’s presence in pet healthcare services, an area that closely aligns with its rural-lifestyle customer base.
Jefferies viewed the acquisition as a potential boost for Allivet PetRx, saying the deal could eventually help the business grow annual revenue from about $100 million to roughly $1 billion.
The firm kept a Buy rating and a $51 price target after the announcement. Analysts also projected an average upside potential of about 52% for Tractor Supply shares at the time of the screen.
Tractor Supply remains tied to rural consumer spending, pet care, farming, home improvement, and outdoor living trends.
8. Fidelity National Information Services
Fidelity National Information Services (NYSE: FIS) has fallen 48.97% from its 52-week high, even as the company continues to work on new fintech partnerships and product expansion.
The stock had a Relative Strength Index of 38.1 on May 29. As of the first quarter, 58 hedge funds also held the stock.
In late May, Truist cut its price target on FIS to $45 from $50 while keeping a neutral stance on the stock. The move came during a broader reassessment of payment and financial technology companies.
FIS has been trying to strengthen its position through new partnerships. One agreement with Fuse is focused on lending technology for auto and equipment finance providers in the United States and Canada.
Another partnership with InvestCloud is designed to support wealth management firms by providing a platform that integrates client portals, advisor tools, workflow features, and AI-supported functions.
Analysts saw an average upside potential of about 37% as of the screen.
FIS remains a major provider of financial technology services. However, investors are still watching payment-sector weakness, margin trends, and the company’s ability to grow in modern banking and wealth technology.
9. Roper Technologies
Roper Technologies (NASDAQ: ROP) offers a different setup from many other names on this list. Although the stock had dropped 44.54% from its 52-week high, the company’s financial results remained strong.
In the first quarter, revenue rose 11% year over year to $2.1 billion, exceeding analyst expectations. Adjusted earnings per share reached $5.16, beating estimates by $0.18.
Management also raised full-year earnings guidance to a range of $21.80 to $22.05 per share. The previous range was $21.30 to $21.55 per share.
Roper also expanded its share repurchase authorization by $3 billion, bringing remaining buyback capacity to $3.8 billion. The company announced a quarterly dividend of $0.91 per share, payable on July 22, 2026, to shareholders of record on July 8.
Wall Street assigned the stock a Moderate Buy rating and projected average upside potential of about 43% at the time of the screen.
Roper operates a portfolio of software and technology-enabled businesses focused on specialized markets.
10. Conagra Brands
Conagra Brands (NYSE: CAG) completed the list after falling 42.05% from its 52-week high. The stock had a Relative Strength Index of 38.7 and was held by 41 hedge funds as of the first quarter.
Analyst sentiment weakened after recent target cuts. BofA lowered its target price to $13 from $15 and maintained an Underperform rating. Wells Fargo also lowered its target to $13 from $14 while keeping an Underweight rating.
Conagra reported fiscal third-quarter revenue of $2.79 billion on April 1. Sales declined 1.9% from the prior year but still came in ahead of analyst expectations.
Adjusted earnings per share were $0.39, down 23.5% year over year and slightly below consensus estimates.
Management moved fiscal 2026 profit guidance toward the lower end of its previous range, citing commodity volatility and broader cost pressure.
Wall Street maintained a Hold rating and projected average upside potential of about 16% as of the screen.
Conagra remains a major branded food company, but its outlook is shaped by inflation, rising input costs, pricing pressure, and cautious consumer spending.
Can These Beaten-Down Stocks Recover?
The contrast between these stocks and the broader market is one of the most important stories of 2026.
The S&P 500 has continued moving higher, and Goldman Sachs expects earnings growth to remain strong through 2027. Yet several large companies inside the index remain deeply discounted.
Some of these stocks are facing real business problems. Charter is losing broadband customers. Insulet is dealing with product and legal concerns. Zoetis is navigating weaker demand for companion animal healthcare. Conagra is struggling with cost pressure and lower earnings.
Others may be suffering more from investor sentiment than from a broken long-term story. CoStar is acquiring to strengthen its real estate data business. Boston Scientific still has strong analyst support. Roper continues to deliver solid earnings growth. FIS is trying to reposition itself through fintech partnerships.
Whether these companies become rebound stories or continue falling will depend on execution. They need to stabilize weak areas, restore investor confidence, and show that current problems are temporary rather than structural.
For now, this group shows how wide the gap can become between headline market strength and individual stock performance. Even in a rising market, some S&P 500 companies can remain under heavy pressure while Wall Street still sees room for recovery.
